Health officials confirmed this week what people who treat or who have attention-deficit/hyperactivity disorder already know: There’s a nationwide shortage of Adderall, the drug widely prescribed for ADHD.
The immediate-release formulation of amphetamine mixed salts, commonly known by the brand name Adderall or Adderall IR, is in short supply, the Food and Drug Administration said Wednesday.
Teva Pharmaceutical Industries, the biggest seller of Adderall in the U.S., “is experiencing ongoing intermittent manufacturing delays,” the agency stated. Other manufacturers continue to produce amphetamine mixed salts, but not in sufficient quantities to meet demand, the FDA added.
Millions of Americans use the stimulant to treat ADHD, with the pills helping those with the disorder concentrate and focus. Amid growing awareness and diagnoses of ADHD, demand for Adderall has escalated in recent years, although the drug is also known for being misused.
There are alternative FDA-approved therapies to treat ADHD, including an extended-release version of amphetamine mixed salts, according to the agency, which urged patients to talk to their doctors about options.
Source from:
SRC: BY KATE GIBSON @ MoneyWatch
Adderall “alternatives” suggestions on amazon.com
